6-K ·Filed Apr 21, 2026
Notable filing: 6-K
Actionable Insight • Neutral
Update ISIN in trading and settlement systems to DK0060615755 to ensure accurate processing of transactions. No investment thesis implications.
Final — all horizons settled through T+60d ⚠ clustered
ASND ▲ +8.12% at T+60d
NEUTRAL call ✓ call won +8.12% · α vs SPY +1.22% · entry $240.29 → $259.80
T+1d
-3.85%
call -3.85% · α -4.86%
$231.05
settled 5mo ago
T+5d
-7.58%
call -7.58% · α -8.66%
$222.08
settled 5mo ago
T+20d
-1.10%
call -1.10% · α -6.02%
$237.64
settled 5mo ago
T+60d
+8.12%
call +8.12% · α +1.22%
$259.80
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Ascendis Pharma A/S updated the International Securities Identification Number (ISIN) for its ordinary shares to DK0060615755 following its direct listing on Nasdaq, replacing the previously disclosed ISIN DK0060606333. The CUSIP number and ticker symbol (ASND) remain unchanged.
Key Facts
- Updated ISIN for ordinary shares to DK0060615755 as confirmed by Denmark's National Numbering Agency
- Previous ISIN DK0060606333 is no longer valid
- CUSIP number (K08588103) and ticker symbol (ASND) remain unchanged
- Update relates to administrative details following direct listing on Nasdaq
Financial Impact
No financial impact
none
Risk Factors
- Potential for trade fails or settlement issues if outdated ISIN is used
- Temporary confusion among investors or systems not updated with new ISIN
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001193125-26-165330 |
| Document: 0001193125-26-165330-index-headers.html | 0001193125-26-165330 |
| Document: 0001193125-26-165330-index.html | 0001193125-26-165330 |
| Document: 0001193125-26-165330.txt | 0001193125-26-165330 |
29 reports for ASND
85% Hit rate best @ T+20▲ +26.62%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | Insider Cluster | $260.81 $247.69 | ▼ −5.03% | ▼ −4.37% | $227.23 (−12.88%) |
Aug 31, 2026 4w ago | 6-K | $260.25 $260.81 | ▲ +0.22% | ▲ +0.13% | $227.23 (−12.69%) |
Aug 27, 2026 5w ago | ANALYST-UPGRADE | $249.36 $271.12 | ▲ +8.73% | ▲ +8.46% | $227.23 (−8.87%) |
Aug 19, 2026 6w ago | ANALYST-UPGRADE | $259.62 $250.25 | ▼ −3.61% | ▼ −3.22% | $227.23 (−12.48%) |
Aug 19, 2026 6w ago | Insider Buy | $259.62 $250.25 | ▼ −3.61% | ▼ −3.22% | $227.23 (−12.48%) |
Aug 13, 2026 7w ago | 6-K | $246.23 $254.81 | ▲ +3.48% | ▲ +5.45% | $227.23 (−7.72%) |
Aug 13, 2026 7w ago | Press Release | $246.23 $254.81 | ▲ +3.48% | ▲ +5.45% | $227.23 (−7.72%) |
Aug 6, 2026 8w ago | 6-K | $249.85 $246.23 | ▼ −1.45% | ▼ −2.66% | $227.23 (−9.05%) |
Aug 6, 2026 8w ago | Press Release | $249.85 $246.23 | ▼ −1.45% | ▼ −2.66% | $227.23 (−9.05%) |
Jul 15, 2026 11w ago | 6-K | $259.80 $252.66 | ▼ −2.75% | ▼ −1.08% | $227.23 (−12.54%) |
Showing 10 of 29
US Market Status
Market Open — Closes in 3h 57m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access